Schmidt P J Investment Management Inc Bristol Myers Squibb CO Transaction History

Schmidt P J Investment Management Inc

$563 Million
Q4 2024

A detailed history of Schmidt P J Investment Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schmidt P J Investment Management Inc holds 6,479 shares of BMY stock, worth $395,802. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,479

Previous 7,450 13.03%

Holding current value

$395,802

Previous $385,000 4.94%

% of portfolio

0.06%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$51.92 - $59.94 $50,414 - $58,201	-971 Reduced 13.03%	6,479 $366,000
Q3 2024 Oct 23, 2024	SELL	$39.66 - $51.75 $81,342 - $106,139	-2,051 Reduced 21.59%	7,450 $385,000
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $160,436 - $211,218	-3,986 Reduced 29.55%	9,501 $394,000
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $128,346 - $145,520	-2,675 Reduced 16.55%	13,487 $731,000
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $195,519 - $233,309	-4,033 Reduced 19.97%	16,162 $829,000
Q3 2023 Oct 20, 2023	SELL	$57.89 - $64.73 $81,046 - $90,622	-1,400 Reduced 6.48%	20,195 $1.17 Million
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $50,968 - $56,591	-800 Reduced 3.57%	21,595 $1.38 Million
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $38,768 - $43,972	-590 Reduced 2.57%	22,395 $1.55 Million
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $31,500 - $37,301	-460 Reduced 1.96%	22,985 $1.65 Million
Q2 2022 Aug 24, 2022	SELL	$72.62 - $79.98 $13,362 - $14,716	-184 Reduced 0.78%	23,445 $1.71 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $5,287 - $6,339	-86 Reduced 0.36%	23,629 $1.73 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $85,808 - $100,032	-1,600 Reduced 6.32%	23,715 $1.54 Million
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $110,943 - $129,956	-1,875 Reduced 6.9%	25,315 $1.47 Million
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $37,146 - $40,452	-600 Reduced 2.16%	27,190 $1.86 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $17,802 - $20,022	-300 Reduced 1.07%	27,790 $1.75 Million
Q4 2020 Feb 01, 2021	SELL	$57.74 - $65.43 $43,997 - $49,857	-762 Reduced 2.64%	28,090 $1.73 Million
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $266,302 - $295,098	4,637 Added 19.15%	28,852 $1.7 Million
Q2 2020 Jul 29, 2020	SELL	$54.82 - $64.09 $27,410 - $32,045	-500 Reduced 2.02%	24,215 $1.42 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $20,416 - $29,669	-440 Reduced 1.75%	24,715 $1.38 Million
Q4 2019 Jan 24, 2020	SELL	$49.21 - $64.19 $43,796 - $57,129	-890 Reduced 3.42%	25,155 $1.62 Million
Q3 2019 Oct 23, 2019	SELL	$42.77 - $50.71 $64,711 - $76,724	-1,513 Reduced 5.49%	26,045 $1.32 Million
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $167,637 - $185,370	-3,757 Reduced 12.0%	27,558 $1.25 Million
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $4,512 - $5,380	-100 Reduced 0.32%	31,315 $1.49 Million
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $84,598 - $109,704	-1,735 Reduced 5.23%	31,415 $1.63 Million
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $909,586 - $1.03 Million	-16,481 Reduced 33.21%	33,150 $2.06 Million
Q2 2018 Jul 24, 2018	SELL	$50.53 - $62.98 $464,825 - $579,353	-9,199 Reduced 15.64%	49,631 $2.75 Million
Q1 2018 Apr 24, 2018	SELL	$59.92 - $68.98 $1.32 Million - $1.52 Million	-22,107 Reduced 27.31%	58,830 $3.72 Million
Q4 2017 Jan 30, 2018	BUY	$59.94 - $65.35 $4.85 Million - $5.29 Million	80,937	80,937 $4.96 Million

Others Institutions Holding BMY

# of Institutions

2,761

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $130B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schmidt P J Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schmidt P J Investment Management Inc with notifications on news.

Account

Schmidt P J Investment Management Inc Bristol Myers Squibb CO Transaction History